NCT00150020View on ClinicalTrials.gov

Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance

PHASE4CompletedINTERVENTIONAL
Enrollment

728

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2006

Conditions
Renal Transplantation
Interventions
DRUG

Enteric-coated mycophenolate sodium (EC-MPS)

Trial Locations (1)

Unknown

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY